| Literature DB >> 30647645 |
Mobeen Shaik1, G Girija Sankar1, M Iswarya1, P Rajitha1.
Abstract
The significance and frequency of marine microorganisms as producers of bioactive metabolites-a natural source of drug discovery had varied significantly during the last decades, making marine ecosystem a huge treasure trove of novel isolates and novel compounds. Among the twelve actinomycetes isolated from marine sediment sample (Lat. 17°41'962″N, Long. 83°19'633″E), amylase, protease, lipase and cellulase activities were exhibited by 8,7,4,3 isolates respectively. Five isolates exhibited l-asparaginase activity, while 5, 6, 2 isolates exhibited antibacterial, antifungal and antimicrobial activities respectively. One isolate VMS-A10 efficiently producing alpha-amylase (25.53 ± 0.50 U/mL), protease (19.26 ± 0.25 U/mL), lipase (36.25 ± 0.10 U/mL), cellulase (14.43 ± 0.513 U/mL), l-asparaginase (0.125 ± 0.004 U/mL), antimicrobial metabolites against B. subtilis (503.33 ± 5.77 U/mL), S. aureus (536.66 ± 5.77 U/mL), E. coli (533.33 ± 5.77 U/mL), P. aeruginosa (500.00 ± 10.0 U/mL), MRSA (538.33 ± 5.77 U/mL), C. albicans (353.33 ± 11.54 U/mL) and A. niger (443.33 ± 15.27 U/mL) was selected, identified on the basis of morphological, cultural, physiological, and biochemical properties together with 16S rDNA sequence, designated as Streptomyces parvulus strain sankarensis-A10 and sequencing product (1490 bp) was deposited in the GenBank database under accession number KT906299, Culture Deposit No: NCIM-5601. Isolation and characterization of each potential actinobacteria having immense industrial and therapeutic value on an unprecedented scale from marine sediments of Visakhapatnam coast will have a burgeoning effect.Entities:
Keywords: Actinomycetes; Bioactive metabolites; Enzyme assays; Phenotypic and genotypic characterization; Streptomyces
Year: 2017 PMID: 30647645 PMCID: PMC6296567 DOI: 10.1016/j.jgeb.2017.02.004
Source DB: PubMed Journal: J Genet Eng Biotechnol ISSN: 1687-157X
Physicochemical properties of the sediment sample.
| Sample | Temperature | pH | Salinity | Dissolved oxygen (D.O) | Biochemical Oxygen Demand (B.O.D) |
|---|---|---|---|---|---|
| Sediment | 26 °C | 7.8 | 32 ppt | 5.12 mg/L | 1.13 mg/L |
ppt-Parts per thousand.
Primary screening of the Actinomycetes isolates for bioactive metabolites.
| S.No | Isolate | Alpha amylase | Protease | Lipase | Cellulase | Antimicrobial activity | ||
|---|---|---|---|---|---|---|---|---|
| Anti-bacterial | Anti-fungal | |||||||
| 1 | VMS-A1 | + | + | − | − | − | + | − |
| 2 | VMS-A2 | + | − | + | − | − | − | + |
| 3 | VMS-A3 | + | − | + | − | + | − | − |
| 4 | VMS-A4 | − | − | − | + | − | + | − |
| 5 | VMS-A5 | − | + | − | − | − | − | + |
| 6 | VMS-A6 | + | + | − | + | − | + | + |
| 7 | VMS-A7 | + | − | − | − | + | + | − |
| 8 | VMS-A8 | − | + | + | − | − | − | − |
| 9 | VMS-A9 | + | + | − | − | + | − | + |
| 10 | + | + | + | + | + | + | + | |
| 11 | VMS-A11 | − | + | − | − | − | − | + |
| 12 | VMS-A12 | + | − | − | − | + | − | − |
+ Showed activity, − No activity.
Screening of isolate VMS-A10 for bioactive metabolites.
| α-Amylase | Protease | Lipase | Cellulase | ||
|---|---|---|---|---|---|
| Zone of Clearance (mm)/Growth (mm) | 30/7 | 22/6 | 27/6 | 20/5 | 28/5 |
| Enzyme activity (U/mL) | 25.53 ± 0.50 | 19.26 ± 0.25 | 36.25 ± 0.10 | 14.43 ± 0.513 | 0.125 ± 0.004 |
Mean ± SD, where n = 3.
Figure 1(A) Antibacterial activity (cross streak method). (B) Spore chain morphology of isolate VMS-A10 under 400× magnification (right).
Figure 2Bioactive metabolites produced by isolate VMS-A10 indicating (A) Alpha amylase. (B) Lipase. (C) l-Asparaginase. (D) Casein hydrolysis. (E) Cellulase. (F) Antibacterial activities.
Antimicrobial activity profile of isolate VMS-A10.
| S.No. | Microorganism | Agar overlay method zone of Inhibition (mm) | Ethylacetate extract zone of Inhibition (Cup plate method) (U/mL) |
|---|---|---|---|
| 1 | 45.43 ± 0.40 | 503.33 ± 5.77 | |
| 2 | 50.53 ± 0.30 | 536.66 ± 5.77 | |
| 3 | 48.23 ± 0.20 | 533.33 ± 5.77 | |
| 4 | 43.10 ± 0.10 | 500.00 ± 10.00 | |
| 5 | MRSA | 51.82 ± 0.71 | 538.33 ± 5.77 |
| 6 | 13.30 ± 0.26 | 353.33 ± 11.54 | |
| 7 | 18.23 ± 0.25 | 443.33 ± 15.27 |
Excluding the growth diameter of VMS-A10.
Excluding the diameter of the well/cup (6 mm).
Mean ± SD where n = 3.
MRSA-clinical isolate acquired from King George Hospital, Visakhapatnam, India.
Phenotypic characteristics of VMS-A10.
| Properties | Strain VMS-A10 |
|---|---|
| Gram staining | Positive |
| Spore surface | Warty |
| Cell wall composition | Chemotype-I |
| 12 | − |
| 25 | + |
| 37 | + |
| 42 | + |
| 5 | + |
| 8 | + |
| 9 | + |
| 10 | + |
| 2 | + |
| 5 | + |
| 7 | + |
| 10 | − |
| Melanin production | − |
| Gelatin liquefaction | + |
| Citrate utilization | − |
| Methyl Red | − |
| Voge’s Proskauer | − |
| Nitrate reduction | + |
| Indole production | − |
| H2S production | − |
| Catalase | − |
| Oxidase | + |
| Urease | − |
| Arabinose | + |
| Dextrose | + |
| Fructose | + |
| Glucose | + |
| Galactose | + |
| Mannose | + |
| Meso-inositol | − |
| Raffinose | − |
| Rhamnose | + |
| Salicin | − |
| Starch | + |
| Sucrose | − |
| Xylose | − |
| + | |
| + | |
| + | |
| + | |
| + | |
| KNO3 | + |
+ Positive, − Negative.
Growth characteristics of the isolate VMS-A10.
| S.No | Media | Growth | Aerial mycelium color | Substrate mycelium color | Pigmentation |
|---|---|---|---|---|---|
| 1. | Starch casein agar | Excellent | Light grey | Greenish yellow | Pale yellow |
| 2. | Tryptone yeast extract agar (ISP 1) | Good | Whitish grey | – | N |
| 3. | Yeast extract malt extract agar (ISP 2) | Excellent | Whitish grey | Brown | Pale yellow |
| 4. | Oat meal agar (ISP 3) | Good | Whitish grey | Yellow | |Pale yellow |
| 5. | Inorganic salt starch agar (ISP 4) | Excellent | Whitish grey | Greenish brown | N |
| 6. | Glycerol asparagine agar (ISP 5) | Excellent | Whitish grey | Greenish | N |
| 7. | Nutrient agar | Excellent | Whitish grey | Pale yellow | Pale yellow |
| 8. | Bennett agar | Excellent | Grey | Brown | Pale yellow |
N - No pigmentation.
Figure 3Scanning electron micrograph of VMS-A10.
Antibiotic sensitivity and resistance profile of isolates VMS-A10.
| S.No. | Antibiotic (µg/mL) | Growth Response | Result | MAR Index |
|---|---|---|---|---|
| 1. | Penicillin G (10 IU) | + | Resistant | 0.60 |
| 2. | Streptomycin (100) | − | Sensitive | |
| 3. | Gentamycin (100) | − | Sensitive | |
| 4. | Rifampicin (50) | + | Resistant | |
| 5. | Tetracyclin (100) | + | Resistant |
+ Growth, − No growth, MAR - Multiple Antibiotic Resistance index.
Figure 4Phylogenetic tree using neighbor-joining method for the isolate VMS-A10.